New Migraine Treatments: Promising Results from Recent Trials

Research Summary

A systematic review published in Cureus highlights recent trends in the pharmacological treatment of chronic migraine. Analyzing data from 14 randomized controlled trials with sample sizes ranging from 1,072 to 2,436 participants, researchers identified eptinezumab, onabotulinumtoxinA, and galcanezumab as common treatments. These studies demonstrated significant improvements in headache frequency, severity, and quality of life metrics, using tools like the Headache Impact Test-6 and Migraine Disability Assessment score. The review concludes that these newer treatments are effective and safe, offering notable enhancements in both clinical outcomes and quality of life for patients suffering from chronic migraine.

Study Details

📄 Title: Recent Trends in the Pharmacological Treatment of Chronic Migraine: A Systematic Review of Randomized Controlled Trials.

👥 Research Team: Sharma J, Soni R, Singh S

📚 Published In: Cureus

📅 Publication Date: 2025 Oct

⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.